MedTrace Logo

Objective Quality of Life Detection Validation

NCT04121793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2020-08-12

No results posted yet for this study

Summary

The purpose of this research study is to:

* Collect data to use in the development of a standardized tool for identifying patients with Parkinson's disease (PD) who would benefit from advanced therapies (AT) such as deep brain stimulation (DBS) and drug pumps.
* Determine the level to which specific activities reflect with quality of life in individuals with PD.
* Obtain feedback from individuals with Parkinson's disease and clinicians on the usability of the system.

Conditions

  • Parkinson Disease

Interventions

DEVICE

Kinesia 360 and Smartphone sensors

Data will be recorded from the Kinesia 360 system and smartphone sensors using the AWARE Framework.

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Great Lakes NeuroTechnologies Inc.

    lead INDUSTRY

Principal Investigators

  • Dustin Heldman, PhD · Director of Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-20
Primary Completion
2020-06-30
Completion
2020-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04121793 on ClinicalTrials.gov